Axi is a brand name of AxiCorp Financial Services Pty Ltd (ACN 127 606 348 and NZBN 9429042567608) (Axi). Axi holds an Australian Financial Services Licence (AFSL number 318232) and a New Zealand Derivatives Issuer Licence (NZ FSP 518226).
Investing in over-the-counter derivatives carries significant risks and is not suitable for all investors. You could lose your initial investment. Retail Clients of Australia and New Zealand are given the added protection of negative balance protection. This means that you cannot lose more than the amount of money invested with us. Investing in CFDs does not provide any entitlement, right or obligation to the underlying financial asset.
Information contained on this website is of a general nature only. Axi does not consider your financial objectives or personal circumstances. Axi recommends that you seek independent advice.
All services are provided on an execution-only basis and no communication should be construed as a recommendation or opinion to buy, hold or sell any of the financial products issued by Axi.
A Product Disclosure Statement (PDS)
, Financial Services Guide (FSG)
and Target Market Deteminations (TMDs)
are available at our website or can be obtained free of charge by calling AxiCorp on 1300 888 936 (+61 2 9965 5830) or New Zealand 0800 480 404. The PDS, FSG and TMDs and should be reviewed prior to opening an account with Axi and deciding whether to acquire, hold or dispose of Axi’s financial products.
The New Zealand Product Disclosure Statement and relevant supplementary documents issued by AxiCorp Financial Services Pty Limited (Axi) under the Financial Markets Conduct Act 2013 have been lodged on the New Zealand Disclose Register. You can obtain copies of these documents from the New Zealand Disclose Register, or by clicking here.
The information on this website is intended for Australian and New Zealand residents only.